Ignite Creation Date:
2024-05-05 @ 4:36 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00278213
Status:
COMPLETED
Last Update Posted:
2018-05-11
First Post:
2006-01-16
Brief Title:
Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
Sponsor:
Organization:
German CLL Study Group